Lacosamide Olpha (Lacosamide)

Lacosamide is an antiepileptic drug indicated for seizure disorders and is used as an add‑on therapy in epilepsy management.

• Partial‑onset seizures: reduces seizure frequency when added to existing antiepileptic regimens.
• Primary generalized tonic‑clonic seizures: used as adjunctive treatment to improve overall seizure control.
• Focal epilepsy: helps achieve better control of focal seizure activity.

• Lacosamide enhances the slow inactivation of voltage‑gated sodium channels, stabilizing neuronal membranes and reducing hyperexcitability. It also binds to the collapsin response mediator protein‑2 (CRMP2), modulating neuronal signaling pathways involved in seizure propagation.

Lacosamide may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

• Dizziness: sensation of light‑headedness or unsteadiness.
• Nausea: feeling of stomach upset or urge to vomit.
• Fatigue: persistent tiredness or lack of energy.
• Headache: mild to moderate cranial pain.
• Blurred vision: temporary visual disturbances.
• Somnolence: increased sleepiness during the day.

Serious or Rare Side Effects

• Cardiac conduction abnormalities: PR interval prolongation that may lead to arrhythmia.
• Suicidal ideation: emergence of thoughts of self‑harm.
• Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Hypersensitivity: rash, swelling, or anaphylactic responses.
• Elevated liver enzymes: indicating potential hepatic stress.

When prescribing Lacosamide, clinicians should consider several safety aspects.

• Renal impairment: dose adjustment may be required based on renal function.
• Hepatic impairment: monitor liver function tests and adjust dosing if needed.
• Cardiac conduction: obtain baseline ECG and monitor for PR interval changes.
• Pregnancy: risk category unknown; use only if benefits outweigh potential risks.
• Concomitant CNS depressants: may increase sedation and respiratory depression.
• Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Lacosamide can interact with other medicines, influencing its efficacy and safety. Major Interactions (Avoid):\n- Class I antiarrhythmics: may exacerbate PR interval prolongation.

• Strong CYP3A4 inhibitors (e.g., ketoconazole): increase lacosamide plasma concentrations.
• Strong CYP3A4 inducers (e.g., carbamazepine): reduce lacosamide levels, diminishing effectiveness.

Moderate Interactions (Monitor Closely)

• Other antiepileptic drugs: may require dose adjustments to maintain seizure control.
• Alcohol: additive central nervous system depression, increasing drowsiness.
• Tramadol: may raise the risk of seizures when used together.